De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. Androdias G, Lunemann JD, Maillart E, Amato MP, et al. Brain 2024 Dec 21:awae409. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Androdias G, Lunemann JD, Maillart E, Amato MP, et al. De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. Brain 2024 Dec 21:awae409. doi: 10.1093.
PMID: 39707906